DDR defects are common in various types of cancer and are also observed in about 20% of mCRPC, in which the most frequent mutations are localized in the homologous recombination repair (HRR) genes, like ATM, BRCA1 and BRCA2 [14]. This evidence concerns the gene BRCA2 and cancer.